Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Venkatesh Madhugiri"'
Autor:
Nair, Anjali1, Venkatesh, Madhugiri Prakash1,2 venkateshmpv@jssuni.edu.in
Publikováno v:
International Journal of Pharmaceutical Investigation. Jul-Sep2023, Vol. 13 Issue 3, p413-421. 9p.
Publikováno v:
Indian Journal of Pharmaceutical Education and Research. 57:s1-s6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59badea5d61d32e1967d8d62bb797909
https://doi.org/10.5530/ijper.57.1s.1
https://doi.org/10.5530/ijper.57.1s.1
Publikováno v:
International Journal of Pharmaceutical Investigation; Jan-Mar2024, Vol. 14 Issue 1, p1-9, 9p
Autor:
Babu, Someshbabu Ramesh, Shekara, Harshith Hosahalli, Sahoo, Ashish Kumar, Harsha Vardhan, Pyda Venkata, Thiruppathi, Nitheesh, Venkatesh, Madhugiri Prakash
Publikováno v:
Therapeutic Delivery; Sep2023, Vol. 14 Issue 9, p571-594, 24p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Shinde, Chetan1 (AUTHOR), Venkatesh, Madhugiri Prakash1 (AUTHOR), Pramod Kumar, Tegginmat1 (AUTHOR), Pai, Deeksha Ramananda1 (AUTHOR)
Publikováno v:
Autoimmunity. Feb2021, Vol. 54 Issue 1, p35-44. 10p.
Publikováno v:
International Journal of Pharmaceutical Investigation; Jul-Sep2023, Vol. 13 Issue 3, p432-439, 8p
Publikováno v:
Neurology India. 69(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1c9c43c81b50c95df34a390f829493b
https://pubmed.ncbi.nlm.nih.gov/34979721
https://pubmed.ncbi.nlm.nih.gov/34979721
Publikováno v:
Clinical Neurology and Neurosurgery. 168:153-162
Objectives For patients who develop brain metastases from solid tumors, age, KPS, primary tumor status and presence of extracranial metastases have been identified as prognostic factors. However, the factors that affect survival in patients who are d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c046f40265fd0788c0b28ee950f6752
https://doi.org/10.1016/j.clineuro.2018.03.011
https://doi.org/10.1016/j.clineuro.2018.03.011
Autor:
Shivali Narang, Donnie Kim, Anita Rao, Michelle M. Kim, Sunil Krishnan, Ganesh Rao, Salmaan Ahmed, Katherine Dextraze, Abhijoy Saha, Arvind Rao, Saphal Narang, Michael Lehrer, Dinesh S. Rao, Venkatesh Madhugiri, Clifton D. Fuller
Publikováno v:
Oncotarget
Glioblastoma (GBM) show significant inter- and intra-tumoral heterogeneity, impacting response to treatment and overall survival time of 12-15 months. To study glioblastoma phenotypic heterogeneity, multi-parametric magnetic resonance images (MRI) of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::023367140c429aad93e53c066ad08721
http://europepmc.org/articles/PMC5762568
http://europepmc.org/articles/PMC5762568